Surgery Today

, Volume 43, Issue 3, pp 293–299

Significant correlation between endothelial nitric oxide synthase (eNOS) expression and alveolar repair in elastase-induced rat pulmonary emphysema

  • Hiromichi Ito
  • Shonosuke Matsushita
  • Shigemi Ishikawa
  • Yukinobu Goto
  • Mitsuaki Sakai
  • Masataka Onizuka
  • Yukio Sato
  • Yuzuru Sakakibara
Original Article


Background and purpose

Angiogenic factors, such as endothelial nitric oxide synthase (eNOS), are thought to play an important role in the repair of pulmonary emphysema (PE); yet, the correlation of the factors involved has not been investigated. We conducted this study to clarify the positive correlation between eNOS expression and alveolar repair in PE recovery.


We used elastase to induce PE in rats, which were divided into Groups A (Control), B (G-CSF), C (PE) and D (PE + G-CSF). G-CSF was injected for 12 days, 4 weeks after which the alveolar walls, arterioles, and angiogenic factors including eNOS were examined histopathologically and by western blotting.


In comparing Groups A, B, C, and D, the alveolar density was 2.4 ± 0.2, 2.4 ± 0.1, 1.8 ± 0.1, 2.5 ± 0.1 per 100 μm2, respectively (C vs. others; p < 0.00001) and the number of arterioles was 4.5 ± 1.0, 5.6 ± 0.6, 3.2 ± 0.5, 5.5 ± 0.7/mm2, respectively (C vs. others; p < 0.05). Immunohistochemical staining (IHC) revealed different eNOS expression in Group D versus Group C (p < 0.0001) and western blotting revealed different eNOS, VEGF, and FLT-1 expression in Group D versus Group C (p < 0.01, p < 0.05, p < 0.001), reflecting the contribution of angiogenesis to PE repair. eNOS showed a significantly positive correlation to alveolar density and arteriole repair.


Alveolar repair was correlated positively with eNOS expression by vascular regeneration in elastase-induced rat PE.


Neovascularization Emphysema eNOS Angiogenic factor G-CSF 


  1. 1.
    Fernandes EO, Teixeira C, Silva LC. Thoracic surgery: risk factors for postoperative complications of lung resection. Rev Assoc Med Bras. 2011;57:292–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Burrows B, Fletcher CM, Heard BE, Jones NL, Wootliff JS. The emphysematous and bronchial type of chronic airways obstruction. A clinicopathological study of patient in London and Chicago. Lancet. 1996;1:1355–60.Google Scholar
  3. 3.
    Takahashi S, Nakamura H, Seki M, Shiraishi Y, Yamamoto M, Furuuchi M. Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol. 2008;294:882–90.CrossRefGoogle Scholar
  4. 4.
    Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003;9:1370–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Siafakas NM, Antoniou KM, Tzortzaki EG. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Dis. 2007;2:453–62.Google Scholar
  6. 6.
    Magee F, Wright JL, Wiggs BR, Paré PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988;43:183–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Barberà JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med. 2001;164:709–13.PubMedGoogle Scholar
  8. 8.
    Lee JH, Lee DS, Kim EK, Choe KH, Oh YM, Shim TS, et al. Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med. 2005;172:987–93.PubMedCrossRefGoogle Scholar
  9. 9.
    Leuwerke SM, Kaza AK, Tribble CG, Kron IL, Laubach VE. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1272–8.PubMedGoogle Scholar
  10. 10.
    Park KW, Kwon YW, Cho HJ, Shin JI, Kim YJ, Lee SE, et al. G-CSF exerts dual effects on endothelial cells—opposing actions of direct eNOS induction versus indirect CRP elevation. J Mol Cell Cardiol. 2008;45:670–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Dunnill MS. Evaluation of a simple method of sampling the lung for quantitative histological analysis. Thorax. 1964;19:443–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Kaza AK, Kron IL, Kern JA, Long SM, Fiser SM, Nguyen RP, et al. Retinoic acid enhances lung growth after pneumonectomy. Ann Thorac Surg. 2001;71:1645–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Thurlbeck WM. Internal surface area and other measurements in emphysema. Thorax. 1967;22:483–96.PubMedCrossRefGoogle Scholar
  14. 14.
    Heemskerk-Gerritsen BA, Dijkman JH, Ten Have-Opbroek AA. Stereological methods: a new approach in the assessment of pulmonary emphysema. Microvasc Res Tech. 1996;34:556–62.CrossRefGoogle Scholar
  15. 15.
    Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol. 2004;172:1266–72.PubMedGoogle Scholar
  16. 16.
    Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997;3:675–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Peinado VI, Barbera JA, Ramirez J, Gomez FP, Roca J, Jover L, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274:L908–13.PubMedGoogle Scholar
  18. 18.
    Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163:737–44.PubMedGoogle Scholar
  19. 19.
    Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S, et al. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004;556:249–52.PubMedCrossRefGoogle Scholar
  20. 20.
    Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007.PubMedCrossRefGoogle Scholar
  21. 21.
    Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med. 2004;10:143–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391–7.PubMedGoogle Scholar
  23. 23.
    Cai WJ, Kocsis E, Luo X, Schaper W, Schaper J. Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis. Mol Cell Biochem. 2004;264:193–200.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2012

Authors and Affiliations

  • Hiromichi Ito
    • 1
  • Shonosuke Matsushita
    • 1
  • Shigemi Ishikawa
    • 2
  • Yukinobu Goto
    • 1
  • Mitsuaki Sakai
    • 1
  • Masataka Onizuka
    • 1
  • Yukio Sato
    • 1
  • Yuzuru Sakakibara
    • 1
  1. 1.Department of Thoracic Surgery, Graduate School of Comprehensive Human ScienceUniversity of TsukubaTsukubaJapan
  2. 2.Department of Chest SurgeryInternational University of Health and Welfare HospitalNasu-ShiobaraJapan

Personalised recommendations